PRS
BIIB icon

Pinkerton Retirement Specialists’s Biogen BIIB Stock Holding History

Pinkerton Retirement Specialists’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-976
Closed -$278K – 137
2023
Q2 		$278K Sell
976
-263
-21% -$78.3K 0.05% 127
2023
Q1 		$344K Sell
1,239
-46
-4% -$12.7K 0.06% 118
2022
Q4 		$356K Buy
+1,285
New +$363K 0.08% 103
2017
Q1 		– Sell
-24
Closed -$7K – 167
2016
Q4 		$7K Buy
24
+6
+33% +$1.78K ﹤0.01% 428
2016
Q3 		$6K Buy
18
+2
+13% +$592 ﹤0.01% 437
2016
Q2 		$4K Sell
16
-85
-84% -$22.4K ﹤0.01% 473
2016
Q1 		$6K Buy
101
+90
+818% +$23.8K ﹤0.01% 112
2015
Q4 		$3K Hold
11
– – ﹤0.01% 128
2015
Q3 		$3K Hold
11
– – ﹤0.01% 133
2015
Q2 		$4K Buy
+11
New +$4.42K ﹤0.01% 132

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pinkerton Retirement Specialists's BIIB Position: Q3 2023 in Review

Pinkerton Retirement Specialists sold out of Biogen (BIIB) in Q3 2023, closing a stake of 976 shares — an estimated $278K sold.

Pinkerton Retirement Specialists first reported a position in BIIB in Q2 2015 and held it in 10 quarters. The position peaked at $356K in Q4 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Pinkerton Retirement Specialists reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 976 Biogen shares in Q3 2023, an estimated $278K.
  • Pinkerton Retirement Specialists first reported a position in Biogen in Q2 2015 and held it in 10 quarters.
  • Pinkerton Retirement Specialists's Biogen position peaked at $356K in Q4 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Pinkerton Retirement Specialists's 13F filing for Q3 2023, filed 13 Nov 2023.